Full-Life Expands Radiopharmaceutical Reach With $245m Focus-X Buyout

Area Attracting Investors

acquisition deal
Asset acquisition helping Chinese biotechs gain traction in radiopharmaceuticals push • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from China

More from Focus On Asia